Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (2240)	2/7/1998 10:49:00 AM
From: Jasman	Read Replies (2) \| Respond to of 7041

I disagree! TXB buy all the way! I am own shares in TXB and I have looked at their SEC filing and press reports and do not find anything to constitute fraud. In response to TXB's collaboration with LG Chemical in Korea, I don't see any unusual activity at all. LG is a huge conglomerate and a respectable company. Smith Klein is even bigger and more respected. As to Zona, a close friend who work at the company, tell me that ZONA is a definite buy. Many of the employees are using their compensation to buy more ZONA shares. But since I don't own ZONA, I am not going to take a stand. But Bill, accusing a company of fraud should not be taken so lightly. In a limited sense, a corporation may be defamed by remarks to its financial condition, honesty, integrity, etc. In Texas (Zona's and TXB's primary place of business), general damages are peresumed by law. It follows that you and SI can be liable. Although it is very doubtful Zonagen or Texas Biotech will sue, I recommend wording your opinions carefully. Sincerely, Jasman